Strong D M, Pellegrino M A, Ferrone S
In Vitro. 1978 Dec;14(12):989-95. doi: 10.1007/BF02616212.
Cultured human lymphoid cell lines (LCL) are useful as a source of target cells in several immunologic assays. More recently such cells have been used for the serological characterizations of the HLA-DR antigens. Typing of the same LCL in various laboratories during the VII Histocompatibility Workshop has given comparable results with a discordancy rate of less than 10%. This discordancy is likely to reflect the different sources of complement that can greatly alter the results of cytotoxic assays. The presence of naturally occurring antibody in rabbit complement to human cells can be avoided by: (a) absorbing with human cells at 0 degrees C; (b) dilution with human serum; (c) dilution with heat-inactivated rabbit serum; (d) repeated freeze-thawing of the complement; or (e) careful selection of complement by screening procedures. Comparison of the results of HLA-DR typing of LCL with peripheral B-cells of the same donor show good correlations. However, LCL will occasionally give extra reactions perhaps due to the expression of new antigens. LCL can be coated with F(ab')2 fragments from antihuman beta2-microglobulin antibodies that block reactions of HLA-A, -B and -C antibodies allowing for discrimination of anti-DRw activity.
培养的人淋巴样细胞系(LCL)在多种免疫测定中作为靶细胞来源很有用。最近,此类细胞已用于HLA - DR抗原的血清学鉴定。在第七届组织相容性研讨会上,不同实验室对同一LCL进行分型得到了可比的结果,不一致率低于10%。这种不一致可能反映了补体来源不同,其可极大改变细胞毒性测定结果。兔补体中针对人细胞的天然抗体的存在可通过以下方法避免:(a)在0℃用人细胞吸收;(b)用人血清稀释;(c)用热灭活兔血清稀释;(d)补体反复冻融;或(e)通过筛选程序仔细选择补体。对同一供体的LCL与外周B细胞进行HLA - DR分型结果比较显示出良好的相关性。然而,LCL偶尔可能会产生额外反应,这可能是由于新抗原的表达。LCL可用抗人β2 - 微球蛋白抗体的F(ab')2片段包被,该片段可阻断HLA - A、-B和 - C抗体的反应,从而区分抗DRw活性。